Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 234551

Known as: SB-234551 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Mismatches between tissue perfusion-weighted imaging (PWI; an index of blood flow deficit) and cellular diffusion-weighted… Expand
2001
2001
In conscious, freely moving, male, Long Evans rats, regional haemodynamic responses to exogenous endothelin‐1 (ET‐1; 25, 50 and… Expand
2001
2001
The role of endothelin B (ETB) receptors in mediating ET ligand‐induced contractions in mouse trachea was examined in ETB… Expand
2000
2000
Increased levels of endothelin (ET) have been demonstrated in the ischemic brain, and ET receptor antagonism has been shown to… Expand
2000
2000
SB 209670 is a potent antagonist of the vasoconstrictor (ETA‐ and ETB‐receptor‐mediated) and vasodilator (ETB‐receptor‐mediated… Expand
1999
1999
The effects of intravenous administration of endothelin (ET) receptor antagonists SB‐209670 (0.001–10.0 mg kg−1), SB‐217242, SB… Expand
Highly Cited
1999
Highly Cited
1999
The role of endothelin B (ET(B)) receptors in inflammation and nociception was examined using ET(B) receptor knockout mice… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
1998
1998
The present study describes the pharmacological profile of ((E)-alpha-[[1-butyl-5-[2-[(2-carboxyphenyl)methoxy]-4-methoxy-phenyl… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3